Vertaling van "humane origine van het " (Nederlands → Frans) :

TERMINOLOGIE

Omschrijving: De belangrijkste klacht betreft hardnekkige, ernstige en kwellende pijn, die niet geheel verklaard kan worden door een fysiologisch proces of een lichamelijke ziekte en die optreedt in samenhang met emotionele conflicten of psychosociale problemen die de conclusie toelaten dat deze de belangrijkste oorzakelijke factoren zijn. Het gevolg is doorgaans een duidelijke toeneming van steun en aandacht, persoonlijk of medisch. Klasseer hier niet de pijn van verondersteld psychogene origine die optreedt in het verloop van depressieve stoornissen of schizofrenie. | Neventerm: | psychalgie | psychogene hoofdpijn | psychogene rugpijn | somatoforme pijnstoornis
Définition: La plainte essentielle concerne une douleur persistante, intense, s'accompagnant d'un sentiment de détresse, non expliquée entièrement par un processus physiologique ou un trouble physique et survenant dans un contexte de conflits émotionnels et de problèmes psycho-sociaux suffisamment importants pour constituer la cause essentielle du trouble selon le clinicien. Le trouble assure habituellement au patient une aide et une sollicitude accrues de la part de son entourage et des médecins. Une douleur considérée comme psychogène mais survenant au cours d'un trouble dépressif ou d'une schizophrénie ne doit pas être classée ici. | Céphalées | Dorsalgie | psychogène(s) | Douleur somatoforme Psychalgie

humane alfa-1-proteinase inhibitor
inhibiteur de la protéinase alpha 1 humaine

humane parainfluenzavirussen
virus para-influenza humainses

humane anti-D-immunoglobulinen
immunoglobuline humaine anti-D

IN-CONTEXT TRANSLATIONS

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

All subjects relating to blood, cells and tissues of human origin have been added as extra fields of competency alongside the existing ones.
All subjects relating to blood, cells and tissues of human origin have been added as extra fields of competency alongside the existing ones.

Bevestigde of waarschijnlijke overdraagbare spongiforme encefalopathie Aanwezigheid of verdacht voor centraal neurologische degeneratieve aandoening van ongekende origine Familiale geschiedenis van familiale CJD, Gerstmann-Scheinker disease, fatale familiale insomnia Behandeling met humaan groeihormoon uit extracten van humane hypofysen Implantatie van een oculair weefseltransplant Implantatie van een dura mater allogreffe Voorgeschiedenis van intracraniële heelkunde
Encéphalopathie spongiforme transmissible confirmée ou probable Présence ou soupçon d’une affection dégénérative du système nerveux central d’origine inconnue Antécédents familiaux de CJD familiale, de Gerstmann-Scheinker disease, d’insomnie familiale fatale Traitement par des hormones de croissance humaine provenant d’extraits d’hypophyses humaines Implantation d’un greffon de tissu oculaire Implantation d’une allogreffe de dure-mère Antécédents de chirurgie intracrânienne

vermelding van de humane origine van het weefsel
mention de l'origine humaine du tissu

- 213 Honeybees, Acute Oral Toxicity Test (Original Guideline, adopted 21st September 1998) - 214 Honeybees, Acute Contact Toxicity Test (Original Guideline, adopted 21st September 1998)
- 214 Honeybees, Acute Contact Toxicity Test (Original Guideline, adopted 21st September 1998

Alert System), regardless of their origin (Belgian, within or outside the European Union) ●● Dealing with the non-availability of essential medicines for Belgian patients ●● The secretariat of the advisory commission
Alert System), regardless of their origin (Belgian, within or outside the European Union) ●● Dealing with the non-availability of essential medicines for Belgian patients ●● The secretariat of the advisory commission

However, a fall in the number of RAS incidents originating in Belgium was recorded (30% instead of 47%) ●● The number of class 1 alerts (problems involving life-threatening risks or serious disturbances for the patient) and class 3 alerts (minor deficiencies) remained stable ●● For class 2 alerts (problems that can cause
However, a fall in the number of RAS incidents originating in Belgium was recorded (30% instead of 47%) ●● The number of class 1 alerts (problems involving life-threatening risks or serious disturbances for the patient) and class 3 alerts (minor deficiencies) remained stable ●● For class 2 alerts (problems that can cause

Annual report 2007” originated as a trainee’s report by Ann Eeckhout, head of the Communication & Scientific Support service, with the valuable cooperation of colleagues from the FAMHP.
Annual report 2007” originated as a trainee’s report by Ann Eeckhout, head of the Communication & Scientific Support service, with the valuable cooperation of colleagues from the FAMHP.

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

De werkgroep is per definitie een meer uitgebreide transversale, interdisciplinaire groep en is samengesteld uit de leden van het projectteam plus leden van Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (inclusief voorzitter), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) en Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).
Le groupe de travail est par définition un groupe interdisciplinaire et transversal plus large, et se compose des membres de l’équipe de projet plus des membres du Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (y compris le président), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) et du Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).